Atlas Trials

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Clinical trial NCT02493712 · COMPLETED

Trial details

NCT number
NCT02493712
Sponsor
Holy Stone Healthcare Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colitis, Ulcerative
Start date
2016-01-01
Primary completion
2018-07-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.